Navigation Links
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
Date:5/10/2013

INDIANAPOLIS, May 10, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monotherapy in the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL). The study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy. There were no new safety findings, and the safety data were consistent with previously disclosed studies.

"We are disappointed in the results that we're announcing today," said Richard Gaynor , M.D., vice president, product development and medical affairs for Lilly Oncology.  "However, our oncology pipeline is still one of the most robust across the industry containing more than 20 molecules, including two Phase III molecules in five different tumor types."

Lilly plans to present data from this study at an upcoming scientific meeting.

Lilly will stop development of enzastaurin, which is expected to result in a second-quarter charge to R&D expense of approximately $30 million. The company's previously-issued financial guidance for 2013 remains unchanged.

About the Study
Patients enrolled in PRELUDE had histologically confirmed DLBCL with an International Prognostic Index (IPI) score of three to five at diagnosis. The IPI is a simple, clinical tool that is used to predict survival outcomes for patients with DLBCL. Patients enrolled also achieved a complete response or complete response-unconfirmed to cyclophosphamide, doxorubicin, vincristine, and prednisone, plus rituximab (R-CHOP) therapy. Patients were randomized in a 2:1 fashion to receive enzastaurin or placebo.

Treatment continued until patients developed progres
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
2. Lilly Declares Second-Quarter 2013 Dividend
3. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
4. The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small
5. Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration
6. Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams
7. Lilly Again Named One of DiversityIncs Top 50 Companies for Diversity
8. Lilly Reports First-Quarter 2013 Results
9. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
10. Lilly Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement
11. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014 Statistics released ... and drunk driving increase astronomically during the holidays, beginning ... in many cities. The data, ... Monitoring Systems as part of their annual ... paints a picture of high-risk drinking and increased rates ...
(Date:11/22/2014)... Nov. 21, 2014  Particle Sciences, Inc (PSI), ... developed and manufactured a new innovative vaginal ring ... and Development arm of Exeltis Pharmaceuticals.  According to ... Management at Particle Sciences, "This vaginal ring was ... material sciences and modeling expertise.  We are thrilled ...
(Date:11/22/2014)... 21, 2014 Many power shifts are ... influence of patients in the biopharmaceutical market is ... more than ever, understanding how to effectively acquire, ... is essential. According to recent ... companies spent about two-thirds of their patient-focused dollars ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2
... Brian Catlett has joined the company in the newly ... a key member of Within3,s executive team (including corporate ... provider of online community solutions for life science and ... more than 25 years of financial and operating leadership ...
... MASI ) today announced that its management is scheduled ... Conference at Terranea in Rancho Palos Verdes, California, on Thursday, ... audiocast of the presentation will be available on the Masimo ... will be available following the live presentation. ...
Cached Medicine Technology:Within3 Adds Chief Financial Officer 2Masimo to Present at Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:11/23/2014)... New York, NY (PRWEB) November 23, 2014 ... ) that allege heart attacks, strokes, deep vein ... been filed in a federal multidistrict litigation (MDL) ... Liebhard LLP reports. , Court documents updated ... on Multidistrict Litigation (JPML) show the filing of ...
(Date:11/23/2014)... 23, 2014 Locks-Magnetic.com, a notable magnetic ... Moreover, all the new products are available at low ... manager is proud of the new emergency doors. The ... And customers can choose from several colors. All of ... quality emergency door release is not as easy as ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 SWAccessControl.com's high ... global market. Recently, the company has announced its new ... special offer on these high quality power suppliers. All ... 30% off. The special offer lasts until Dec. 20, ... many of them have been supporting it for a ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Asher ... Medical Aesthetics & Wellness was recently featured on ... Ph.D. is president and CEO of American Medical Aesthetics ... Asher Milgrom received a full scholarship to attend an ... Medical School at the University of Chicago, where his ...
(Date:11/23/2014)... November 23, 2014 Syngenta lawsuits are ... behalf of farmers and agribusinesses that have allegedly incurred ... commercialize Agrisure Viptera and Agrisure Duracade, genetically modified ... approved for sale in China. According to a report ... virtually ban U.S. corn imports. Because China is the ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3
... nor causes injury, according to a study presented today ... of Orthopaedic Surgeons (AAOS). More than 70 million people ... been controversy regarding whether runners should stretch before running, ... who run 10 or more miles per week. Of ...
... COLUMBIA, Mo. Most people know that exercise ... sedentary lifestyles and obesity rates are at all-time ... a new study, University of Missouri researchers found ... behavior-changing strategies significantly increased their physical activity levels. ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Feb. 17 ... start in the United States last fall, but is now circulating ... Pediatric deaths from flu tripled in the past month, jumping ... to the U.S. Centers for Disease Control and Prevention. "We ...
... walls can vary among individuals depending on factors such as ... UC Davis. The new research reinforces the link between ... can lead to heart disease and strokes. Triglycerides are ... to increase risk of inflammation of the endothelium, the layer ...
... National Women In Surgery Career Symposium will be held March ... two of the few women chairs of academic surgery programs ... will be Julie Freischlag, MD, The William Stewart Halsted Professor, ... and Nancy Ascher, MD, PhD, Isis Distinguished Professor of Transplantation ...
... (HealthDay News) -- Arthritis affected about 3.1 million Hispanics in ... wide variations in arthritis rates among Hispanic subgroups, according to ... ranged from a low of 11.7 percent among Cuban Americans ... to the analysis of National Health Interview Survey data from ...
Cached Medicine News:Health News:Stretching before a run does not prevent injury 2Health News:To increase physical activity, focus on how, not why 2Health News:U.S. Flu Season Picking Up, CDC Reports 2Health News:Study reinforces link between obesity, high-fat meals and heart disease 2Health News:National career symposium offers strategic advice to attract, advance women in surgery 2Health News:3.1 Million Hispanic Americans Struggle With Arthritis 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: